APA (7th ed.) Citation

RV, O., SH, I., & CW, T. (2015). Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development. CPT: pharmacometrics & systems pharmacology, 4(10), 565. https://doi.org/10.1002/psp4.12015

Chicago Style (17th ed.) Citation

RV, Overgaard, Ingwersen SH, and Tornøe CW. "Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development." CPT: Pharmacometrics & Systems Pharmacology 4, no. 10 (2015): 565. https://doi.org/10.1002/psp4.12015.

MLA (9th ed.) Citation

RV, Overgaard, et al. "Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development." CPT: Pharmacometrics & Systems Pharmacology, vol. 4, no. 10, 2015, p. 565, https://doi.org/10.1002/psp4.12015.